CSNpharm
Topiramate is a selective GluK1 kainate receptors (GluR5) antagonist with IC50 value of 0.46 μM which can act as a positive allosteric modulator of GABAA receptor-mediated currents, inhibit Nav channels and L-type Ca2+ channels.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
Topotecan HCl is the first topoisomerase I-directed cytotoxic agent to enter clinical trials in the United States.
More Information
Supplier Page
CSNpharm
Topotecan HCl is the first topoisomerase I-directed cytotoxic agent to enter clinical trials in the United States.
More Information
Supplier Page
CSNpharm
Topotecan HCl is the first topoisomerase I-directed cytotoxic agent to enter clinical trials in the United States.
More Information
Supplier Page
TOPS
5g
| ≥95%
CSNpharm
TOPS, an aniline derivative with highly water-solublility, is a Trinder’s reagentand widely used in diagnostic tests and biochemical tests.
More Information
Supplier Page
TOPS
1g
| ≥95%
CSNpharm
TOPS, an aniline derivative with highly water-solublility, is a Trinder’s reagentand widely used in diagnostic tests and biochemical tests.
More Information
Supplier Page
CSNpharm
Torachrysone, a natural product isolated and purified from the seeds of Cassia obtusifolia, shows promising antioxidant activity and noticeable antibacterial effects on four strains of methicillin-resistant Staphylococcus aureus with a minimum inhibitory concentration of 2-64 mg/mL.
More Information
Supplier Page
CSNpharm
Torachrysone, a natural product isolated and purified from the seeds of Cassia obtusifolia, shows promising antioxidant activity and noticeable antibacterial effects on four strains of methicillin-resistant Staphylococcus aureus with a minimum inhibitory concentration of 2-64 mg/mL.
More Information
Supplier Page
CSNpharm
Torachryson-8-O-glucoside, a natural product isolated and purified from the rhizoma of Rheum palmatum, shows alpha-glucosidase inhibitory activities, it may be used for the management of type 2 diabetes.
More Information
Supplier Page
CSNpharm
Torachryson-8-O-glucoside, a natural product isolated and purified from the rhizoma of Rheum palmatum, shows alpha-glucosidase inhibitory activities, it may be used for the management of type 2 diabetes.
More Information
Supplier Page
CSNpharm
Tormentic acid, a natural product isolated and purified from the herb of Potentilla tormentilla with anti-allodynic, anti-inflammatory, anticancer,anti-atherogenic activities, has protective effect against lipopolysaccharide/D-galactosamine induced fulminant hepatic failure in mice.
More Information
Supplier Page
CSNpharm
Tormentic acid, a natural product isolated and purified from the herb of Potentilla tormentilla with anti-allodynic, anti-inflammatory, anticancer,anti-atherogenic activities, has protective effect against lipopolysaccharide/D-galactosamine induced fulminant hepatic failure in mice.
More Information
Supplier Page
CSNpharm
Torsemide is a medication mainly used in the management of fluid overload and peripheral edema associated with congestive heart failure.
More Information
Supplier Page
CSNpharm
Torsemide is a medication mainly used in the management of fluid overload and peripheral edema associated with congestive heart failure.
More Information
Supplier Page
CSNpharm
Tosedostat is a aminopeptidase inhibitor with IC50 of 220, > 1000 nM for aminopeptidase N and aminopeptidase B respectively.
More Information
Supplier Page
CSNpharm
Tosedostat is a aminopeptidase inhibitor with IC50 of 220, > 1000 nM for aminopeptidase N and aminopeptidase B respectively.
More Information
Supplier Page
CSNpharm
Tosedostat is a aminopeptidase inhibitor with IC50 of 220, > 1000 nM for aminopeptidase N and aminopeptidase B respectively.
More Information
Supplier Page
CSNpharm
Tosedostat is a aminopeptidase inhibitor with IC50 of 220, > 1000 nM for aminopeptidase N and aminopeptidase B respectively.
More Information
Supplier Page
CSNpharm
Tosedostat is a aminopeptidase inhibitor with IC50 of 220, > 1000 nM for aminopeptidase N and aminopeptidase B respectively.
More Information
Supplier Page
CSNpharm
Tosedostat is a aminopeptidase inhibitor with IC50 of 220, > 1000 nM for aminopeptidase N and aminopeptidase B respectively.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
TP0427736 HCl is the HCl form of TP0427736 which is an inhibitor of ALK5 with IC50 of 2.72 nM and can reduce TGF-β induced growth.
More Information
Supplier Page
CSNpharm
TP0427736 HCl is the HCl form of TP0427736 which is an inhibitor of ALK5 with IC50 of 2.72 nM and can reduce TGF-β induced growth.
More Information
Supplier Page
CSNpharm
TP0427736 HCl is the HCl form of TP0427736 which is an inhibitor of ALK5 with IC50 of 2.72 nM and can reduce TGF-β induced growth.
More Information
Supplier Page
CSNpharm
TP0427736 HCl is the HCl form of TP0427736 which is an inhibitor of ALK5 with IC50 of 2.72 nM and can reduce TGF-β induced growth.
More Information
Supplier Page
TPEN
100mg
| ≥99%
CSNpharm
TPEN is an intracellular membrane-permeable ion chelator, with high-affinity heavy metal (Zn2+>Fe2+>Mn2+) and low affinity for Mg2+ and Ca2+.
More Information
Supplier Page
TPEN
50mg
| ≥99%
CSNpharm
TPEN is an intracellular membrane-permeable ion chelator, with high-affinity heavy metal (Zn2+>Fe2+>Mn2+) and low affinity for Mg2+ and Ca2+.
More Information
Supplier Page
TPEN
250mg
| ≥99%
CSNpharm
TPEN is an intracellular membrane-permeable ion chelator, with high-affinity heavy metal (Zn2+>Fe2+>Mn2+) and low affinity for Mg2+ and Ca2+.
More Information
Supplier Page
TPI-1
1mg
| ≥98%
CSNpharm
TPI-1 is an SHP1 inhibitor with IC50 of 40 nM selectively increased SHP1 phospho-substrates (pLck-pY394, pZap70 and pSlp76) in Jurkat T cells but had little effects on pERK1/2 or pLck-pY505 regulated by phosphatases SHP2 or CD45, respectively. TPI-1 was shown to be more effective than sodium stibogluconate in SHP1 inhibition, immune cell activation and anti-tumor […]
More Information
Supplier Page
TPI-1
100mg
| ≥98%
CSNpharm
TPI-1 is an SHP1 inhibitor with IC50 of 40 nM selectively increased SHP1 phospho-substrates (pLck-pY394, pZap70 and pSlp76) in Jurkat T cells but had little effects on pERK1/2 or pLck-pY505 regulated by phosphatases SHP2 or CD45, respectively. TPI-1 was shown to be more effective than sodium stibogluconate in SHP1 inhibition, immune cell activation and anti-tumor […]
More Information
Supplier Page
TPI-1
5mg
| ≥98%
CSNpharm
TPI-1 is an SHP1 inhibitor with IC50 of 40 nM selectively increased SHP1 phospho-substrates (pLck-pY394, pZap70 and pSlp76) in Jurkat T cells but had little effects on pERK1/2 or pLck-pY505 regulated by phosphatases SHP2 or CD45, respectively. TPI-1 was shown to be more effective than sodium stibogluconate in SHP1 inhibition, immune cell activation and anti-tumor […]
More Information
Supplier Page
TPI-1
10mg
| ≥98%
CSNpharm
TPI-1 is an SHP1 inhibitor with IC50 of 40 nM selectively increased SHP1 phospho-substrates (pLck-pY394, pZap70 and pSlp76) in Jurkat T cells but had little effects on pERK1/2 or pLck-pY505 regulated by phosphatases SHP2 or CD45, respectively. TPI-1 was shown to be more effective than sodium stibogluconate in SHP1 inhibition, immune cell activation and anti-tumor […]
More Information
Supplier Page
TPI-1
50mg
| ≥98%
CSNpharm
TPI-1 is an SHP1 inhibitor with IC50 of 40 nM selectively increased SHP1 phospho-substrates (pLck-pY394, pZap70 and pSlp76) in Jurkat T cells but had little effects on pERK1/2 or pLck-pY505 regulated by phosphatases SHP2 or CD45, respectively. TPI-1 was shown to be more effective than sodium stibogluconate in SHP1 inhibition, immune cell activation and anti-tumor […]
More Information
Supplier Page
TPMPA
10mg
| ≥98%
CSNpharm
TPMPA
50mg
| ≥98%
CSNpharm
CSNpharm
TR-14035 is a dual antagonist of both integrin α4β7 and integrin α4β1 with IC50 values of 7 nM and 87 nM, respectively, used as an anti-inflammatory agent.
More Information
Supplier Page
CSNpharm
TR-14035 is a dual antagonist of both integrin α4β7 and integrin α4β1 with IC50 values of 7 nM and 87 nM, respectively, used as an anti-inflammatory agent.
More Information
Supplier Page
CSNpharm
TR-14035 is a dual antagonist of both integrin α4β7 and integrin α4β1 with IC50 values of 7 nM and 87 nM, respectively, used as an anti-inflammatory agent.
More Information
Supplier Page
CSNpharm
TR-14035 is a dual antagonist of both integrin α4β7 and integrin α4β1 with IC50 values of 7 nM and 87 nM, respectively, used as an anti-inflammatory agent.
More Information
Supplier Page
CSNpharm
TR-14035 is a dual antagonist of both integrin α4β7 and integrin α4β1 with IC50 values of 7 nM and 87 nM, respectively, used as an anti-inflammatory agent.
More Information
Supplier Page
CSNpharm
Tracheloside, a natural product isolated and purified from the herbs of Trachelospermum jasminoides (Lindl.) Lem., significantly decreases the activity of alkaline phosphatase (AP), an estrogen-inducible marker enzyme, with an IC50 value of 0.31 mg/mL, a level of inhibition comparable to that of tamoxifen (IC50 = 0.43 mg/mL).
More Information
Supplier Page
CSNpharm
Tracheloside, a natural product isolated and purified from the herbs of Trachelospermum jasminoides (Lindl.) Lem., significantly decreases the activity of alkaline phosphatase (AP), an estrogen-inducible marker enzyme, with an IC50 value of 0.31 mg/mL, a level of inhibition comparable to that of tamoxifen (IC50 = 0.43 mg/mL).
More Information
Supplier Page
CSNpharm
Tracheloside, a natural product isolated and purified from the herbs of Trachelospermum jasminoides (Lindl.) Lem., significantly decreases the activity of alkaline phosphatase (AP), an estrogen-inducible marker enzyme, with an IC50 value of 0.31 mg/mL, a level of inhibition comparable to that of tamoxifen (IC50 = 0.43 mg/mL).
More Information
Supplier Page
